SignaIDT Biotechnology (SZ), Inc. received funding for high-level talent entrepreneurship in Bao'an District

Time:

2023-06-06 20:53

On June 27, 2017, Shenzhen Baoan District Science and Technology Innovation Bureau and Shenzhen Baoan District Science and Technology Association announced the first batch of scientific and technological innovation talents in Baoan District in 2017. 300,000 yuan for incubation and entrepreneurship.

There are five types of high-level scientific and technological innovation talent projects announced this time, including (1) talent incubation and entrepreneurship funding, (2) maker team project funding, (3) high-level scientific and technological innovation talents and team supporting venue rental subsidy projects, ( 4) Subsidies for the construction of postgraduate training practice bases, (5) subsidies for doctoral students and master students to carry out research projects in practice bases, are Baoan District Government and Baoan District Committee according to the "Baoan District Implementation" Several measures to promote the priority development of talents "Implementation Plan for >" (Shenbaofa [2016] No. 6) and "Operational Procedures for Implementing the Implementation Plan of <Several Measures for Promoting the Priority Development of Talents> in Bao'an District" (Shenbao Talents [2016] No. 1) vigorously One of the powerful measures to introduce high-level scientific and technological talents is a strong support for innovative start-ups.

SignaIDT Biotechnologies (SZ), Inc. is a high-tech biotechnology company founded by the team of Dr. Lin Jingzhong, a returned overseas student. After settling in Baoan District in 2013, it has received strong support from the Baoan District Government in terms of talents, venues, and R&D funds. The company has built more than 800 square meters of GMP clean workshops in Quanzhi Science and Technology Innovation Park, Shajing, Baoan District. It has passed the verification of relevant departments in May 2017 and officially put into production.

 

Related News